Epofit 5000IU Injection
Images are for reference. Actual packaging may vary.
Recombinant Human Erythropoietin Alfa (5000IU)
Prefilled of 1 injection • Other
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Recombinant Human Erythropoietin Alfa binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their proliferation and differentiation into mature red blood cells.
Medical applications
Epofit 5000IU Injection contains Recombinant Human Erythropoietin Alfa, a glycoprotein hormone that stimulates erythropoiesis, the production of red blood cells, by acting on erythroid progenitor cells in the bone marrow. It is indicated for the treatment of anemia associated with chronic kidney disease (CKD), including patients on dialysis and those not on dialysis, as well as anemia due to chemotherapy in cancer patients and anemia in HIV-infected patients receiving zidovudine therapy.
Epofit 5000IU Injection is also utilized to reduce the need for allogeneic blood transfusions in patients undergoing elective, non-cardiac, non-vascular surgery. The recommended dosage and administration depend on the indication, patient response, and hemoglobin levels, with careful monitoring to avoid excessive erythropoiesis which may increase the risk of thromboembolic events.
The injection is administered subcutaneously or intravenously under medical supervision. Common adverse effects include hypertension, headache, injection site reactions, and flu-like symptoms. Contraindications include uncontrolled hypertension and hypersensitivity to the active substance or any excipients. Epofit 5000IU Injection should be used with caution in patients with risk factors for cardiovascular events, and regular monitoring of hemoglobin, hematocrit, and blood pressure is essential to ensure safe and effective therapy.
Amino Acids, Peptides Analogues
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Epofit 5000IU Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Epofit 5000IU Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Epofit 5000IU Injection is safe to use in patients with kidney disease. No dose adjustment of Epofit 5000IU Injection is recommended. Regular monitoring of kidney function tests is advised while the patient is taking this medicine.
Exercise Caution
Epofit 5000IU Injection may cause side effects which could affect your ability to drive.
Consult Doctor
Epofit 5000IU Injection should be used with caution in patients with liver disease. Dose adjustment of Epofit 5000IU Injection may be needed. Please consult your doctor.
Regular Checkup
0 reviews for Epofit 5000IU Injection







